Sample Size Consideration for Immunoassay Screening Cut-Point Determination

Author：

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.24, Iss.3, 2014-05, pp. : 535-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sample Size Determination for Repeated Measurements in Bioequivalence Test

By Lui Kung-Jong

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 4, 1997-08 ,pp. : 507-513

Springer Publishing Company

Access to resources Recommend Favorite

Sample Size Determination for a Specific Region in a Multiregional Trial

By Ko Feng-Shou

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 4, 2010-07 ,pp. : 870-885

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination for Cost-Effectiveness Trials

By Willan Andrew R.

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 933-949

Adis International

Access to resources Recommend Favorite

Sample Size Determination for Equivalence Assessment with Multiple Endpoints

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1203-1214

Taylor & Francis Ltd

Access to resources Recommend Favorite

Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes

By Stamey James D. Natanegara Fanni Seaman John W.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 790-803

Taylor & Francis Ltd

Access to resources Recommend Favorite